1 year return (CAGR)
-76.83%
MoonLake Immunotherapeutics Exchange (NASDAQ, USD)
MLTX
12.55
+0.16 (+1.29%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-39.76%
5 year return (CAGR)
4.77%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.07B
Price/Sales
-
Ent value
735.94M
Price/Book
2.49
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.50 |
| Daily high | 12.65 |
| Daily low | 12.24 |
| Daily Volume | 1.22M |
| All-time high | 63.86 |
| 1y analyst estimate | 28.54 |
| Beta | 1.03 |
| EPS (TTM) | -3.57 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| MLTX | S&P500 | |
| Current price drop from All-time high | -80.35% | -0.56% |
| Highest price drop | -90.22% | -56.47% |
| Date of highest drop | 29 Sep 2025 | 9 Mar 2009 |
| Avg drop from high | -31.49% | -10.68% |
| Avg time to new high | 27 days | 12 days |
| Max time to new high | 654 days | 1805 days |
News
